新辅助疗法:ER阳性/HER2阴性和三阴性早期乳腺癌的现状和未来视野
Hervé Bischoff1, Marc Espié2, Thierry Petit3
1Medical Oncology Department, Institut de Cancérologie Strasbourg Europe, ICANS, 17 Rue Albert Calmette, 67033, Strasbourg, France. h.bischoff@icans.eu.
Current treatment options in oncology
|August 15, 2024
概括
乳腺癌的治疗方法对于光线和三阴性亚型有所不同. 免疫疗法与化疗相结合正在改变三阴性治疗,而内分泌疗法对一些光线癌症有好处,但有针对性的治疗整合需要更多的研究.
科学领域:
- 在瘤学瘤学.
- 医学研究 医学研究
背景情况:
- 乳腺癌治疗策略在光线和三阴性亚型之间有很大差异.
- 新辅助化疗是治疗三阴性乳腺癌的传统方法.
- 包括芳香酶抑制剂在内的内分泌疗法已用于某些光线乳腺癌.
研究的目的:
- 审查目前针对光线和三阴性乳腺癌的治疗模式.
- 突出免疫疗法在三阴性乳腺癌中的新兴作用.
- 讨论优化乳腺癌治疗的挑战和未来方向.
主要方法:
- 最近临床证据和治疗指南的文献综述.
- 对不同乳腺癌亚型的治疗结果的分析.
- 讨论新兴的治疗策略和预测因素研究.
主要成果:
- 免疫疗法与化疗相结合,对三阴性乳腺癌产生显著影响.
- 内分泌疗法,如芳酶抑制剂,对绝经后的光线A瘤有效.
- 对于光线癌的新辅助设置中CDK4/6抑制剂的作用需要进一步研究.
结论:
- 个性化治疗方法对于优化乳腺癌管理至关重要.
- 了解亚型特异性特征对于有效的治疗选择至关重要.
- 持续的研究是必要的,以确定预测因素和完善治疗策略,特别是在光线乳腺癌.
更多相关视频
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.7K
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.6K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K